Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 3 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency.
J Allergy Clin Immunol. 2018 Dec;142(6):1679-1695. doi: 10.1016/j.jaci.2018.10.026.
J Allergy Clin Immunol. 2018.
PMID: 30527062
Review.
Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy.
Liu JM, Chen P, Uyeda MJ, Cieniewicz B, Sayitoglu EC, Thomas BC, Sato Y, Bacchetta R, Cepika AM, Roncarolo MG.
Liu JM, et al. Among authors: uyeda mj.
Cytotherapy. 2021 Nov;23(11):1017-1028. doi: 10.1016/j.jcyt.2021.05.010. Epub 2021 Aug 15.
Cytotherapy. 2021.
PMID: 34404616
Free PMC article.
Item in Clipboard
Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10).
Comi M, Avancini D, Santoni de Sio F, Villa M, Uyeda MJ, Floris M, Tomasoni D, Bulfone A, Roncarolo MG, Gregori S.
Comi M, et al. Among authors: uyeda mj.
Cell Mol Immunol. 2020 Jan;17(1):95-107. doi: 10.1038/s41423-019-0218-0. Epub 2019 Mar 6.
Cell Mol Immunol. 2020.
PMID: 30842629
Free PMC article.
Item in Clipboard
BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation.
Uyeda MJ, Freeborn RA, Cieniewicz B, Romano R, Chen PP, Liu JM, Thomas B, Lee E, Cepika AM, Bacchetta R, Roncarolo MG.
Uyeda MJ, et al.
Front Immunol. 2021 Jul 7;12:683680. doi: 10.3389/fimmu.2021.683680. eCollection 2021.
Front Immunol. 2021.
PMID: 34305917
Free PMC article.
Item in Clipboard
Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells.
Cieniewicz B, Uyeda MJ, Chen PP, Sayitoglu EC, Liu JM, Andolfi G, Greenthal K, Bertaina A, Gregori S, Bacchetta R, Lacayo NJ, Cepika AM, Roncarolo MG.
Cieniewicz B, et al. Among authors: uyeda mj.
Haematologica. 2021 Oct 1;106(10):2588-2597. doi: 10.3324/haematol.2020.263129.
Haematologica. 2021.
PMID: 33054128
Free PMC article.
Item in Clipboard
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML.
Sayitoglu EC, Luca BA, Boss AP, Thomas BC, Freeborn RA, Uyeda MJ, Chen PP, Nakauchi Y, Waichler C, Lacayo N, Bacchetta R, Majeti R, Gentles AJ, Cepika AM, Roncarolo MG.
Sayitoglu EC, et al. Among authors: uyeda mj.
Leukemia. 2024 May 9. doi: 10.1038/s41375-024-02255-1. Online ahead of print.
Leukemia. 2024.
PMID: 38724673
Item in Clipboard
Human-engineered Treg-like cells suppress FOXP3-deficient T cells but preserve adaptive immune responses in vivo.
Sato Y, Passerini L, Piening BD, Uyeda MJ, Goodwin M, Gregori S, Snyder MP, Bertaina A, Roncarolo MG, Bacchetta R.
Sato Y, et al. Among authors: uyeda mj.
Clin Transl Immunology. 2020 Nov 25;9(11):e1214. doi: 10.1002/cti2.1214. eCollection 2020.
Clin Transl Immunology. 2020.
PMID: 33304583
Free PMC article.
Item in Clipboard
Cite
Cite